Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep;62(9):870-4.
doi: 10.1136/ard.62.9.870.

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

D M Lee  1 , P H Schur
Affiliations

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

D M Lee et al. Ann Rheum Dis. 2003 Sep.

Abstract

Objectives: To determine the frequency of antibodies to cyclic citrullinated peptides (CCP) in a group of patients with a diversity of rheumatic diseases.

Methods: 249 consecutive sera from an arthritis clinic sent for rheumatology testing were selected for testing with the anti-CCP2 assays and for the presence of rheumatoid factor (RF). Patient charts were reviewed for demographic information, clinical diagnosis, radiographic information, and other laboratory data.

Results: The sensitivity and specificity of anti-CCP reactivity for the diagnosis of rheumatoid arthritis (RA) were 66.0% and 90.4%, respectively. This compared with the sensitivity and specificity of RF for RA at 71.6% and 80.3%. Furthermore, 10/29 (34%) RF- patients with RA demonstrated reactivity to CCP. The presence of either anti-CCP or RF increased testing sensitivity for diagnosis of RA to 81.4%; the presence of both RF and anti-CCP demonstrated a testing specificity similar to that of anti-CCP reactivity alone for the diagnosis of RA (91.1%).

Conclusions: The detection of anti-CCP is useful for the diagnosis of RA, in fact even more so than RF, because of its higher specificity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ROC curves for anti-CCP (A) and RF (B) assays. Individual datapoints are represented as small squares. A best fit curve was generated by non-linear regression calculation. Arrows mark the cut off values used for this study.
Figure 2
Figure 2
CCP reactivity in rheumatic disease subsets. Shown are the levels of anti-CCP reactivity in sera from patients with labelled rheumatic diagnoses. Closed squares RF-; open squares RF+.
Figure 3
Figure 3
RF v CCP values. The values in units of RF and CCP activity in 214 rheumatic disease patients are shown. Correlation coefficient (R)=0.34.
Figure 4
Figure 4
Correlation of anti-CCP activity and radiographic joint destruction. The percentage of patients with anti-CCP reactivity and RF relative to the presence of erosions in patients with available radiographs (n=129) is shown.
See this image and copyright information in PMC

References

    1. Rheumatology (Oxford). 2000 Jun;39 Suppl 1:24-9 - PubMed
    1. Ann Rheum Dis. 1964 Jul;23:302-5 - PubMed
    1. J Immunol. 2001 Feb 1;166(3):1492-8 - PubMed
    1. Nat Immunol. 2001 Aug;2(8):746-53 - PubMed
    1. Arthritis Rheum. 2000 Jan;43(1):155-63 - PubMed

MeSH terms